DNMT3B likely plays a role in pathogenesis of various hematologic malignancies as genetic alterations were identified in cutaneous T-cell lymphomas (CTCLs) and B-cell lymphomas (BCLs) (23, 24). This evidence concerns the gene DNMT3B and hematologic disorder.